Navigating the Costs and Insurance Landscape Affordability and insurance coverage are critical factors when it comes to GLP-1 agonists
While programs like TrumpRX may advertise low introductory costs, these prices increase over time
The IRS permits pretax spending on compounded drugs that treat medically diagnosed conditions, including weight-related metabolic disorders
Each increment in BMI of 5 kg/m 2 greater than 22,525,0 kg/m 2 corresponds to a rise in overall mortality of 30% (3), in obese people the major death cause in CVD, followed by T2D (4)
Nutrition priorities in the GLP-1 era Protein for satiety and lean mass preservation One of the most significant concerns for individuals using GLP-1 medications is the potential for excessive lean body mass loss
When your cells are more efficient at energy production, your bodys detox and repair systems can work more effectively, contributing to overall health and vitality